In order to establish potential associations with the clinical outcome of luminal cancer patients, we downloaded standardized survival data from cBioPortal to determine whether over- and underexpression of SH2B3 are associated with overall survival of hormone receptor-positive breast cancer patients. Here, SH2B3 is linked to cancer.